NCT00220090View on ClinicalTrials.gov

DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2003

Primary Completion Date

September 30, 2006

Conditions

Irritable Bowel Syndrome

Interventions

DRUG

dexloxiglumide

Trial Locations (1)

Unknown

Academic Department of Medicine Wythenshawe Hospital, Manchester

All Listed Sponsors

lead

Rottapharm

INDUSTRY

NCT00220090 - DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) | Biotech Hunter | Biotech Hunter